These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16503199)

  • 21. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural determinants of T-cell receptor bias in immunity.
    Turner SJ; Doherty PC; McCluskey J; Rossjohn J
    Nat Rev Immunol; 2006 Dec; 6(12):883-94. PubMed ID: 17110956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged increase in T-cell receptor (TCR) variant fractions of spleen T lymphocytes in pregnant mice after gamma irradiation.
    Igari Y; Igari K; Kunugita N; Ootsuyama A; Norimura T
    Radiat Res; 2007 Jul; 168(1):81-6. PubMed ID: 17722993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell culture for gammaretroviral transfer.
    Newrzela S; Gunda B; von Laer D
    Methods Mol Biol; 2009; 506():71-82. PubMed ID: 19110620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.
    Wagner DH
    Clin Immunol; 2007 Apr; 123(1):1-6. PubMed ID: 16990051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
    Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
    Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial overview: lymphocyte development.
    Weaver CT; Rudensky AY
    Curr Opin Immunol; 2009 Apr; 21(2):119-20. PubMed ID: 19361970
    [No Abstract]   [Full Text] [Related]  

  • 31. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
    Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
    AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making and circumventing tolerance to cancer.
    Kammertoens T; Blankenstein T
    Eur J Immunol; 2009 Sep; 39(9):2345-53. PubMed ID: 19634191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells.
    Lyons GE; Moore T; Brasic N; Li M; Roszkowski JJ; Nishimura MI
    Cancer Res; 2006 Dec; 66(23):11455-61. PubMed ID: 17145893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy.
    Nagymanyoki Z; Butler MO; Callahan MJ; Parast MM; Fulop V; Mok SC; Berkowitz RS
    J Reprod Med; 2008 Jul; 53(7):528-34. PubMed ID: 18720929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of commonly used ferritin assays to the classic hook effect.
    Ranjitkar P; Turtle CJ; Harris NS; Holmes DT; Pyle-Eilola A; Maloney DG; Greene DN
    Clin Chem Lab Med; 2016 Feb; 54(2):e41-3. PubMed ID: 26351953
    [No Abstract]   [Full Text] [Related]  

  • 37. Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.
    Udyavar A; Geiger TL
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):335-46. PubMed ID: 20680493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.
    Rubinstein MP; Salem ML; Kadima AN; Nguyen CL; Gillanders WE; Nishimura MI; Cole DJ
    Cancer Gene Ther; 2009 Feb; 16(2):171-83. PubMed ID: 18690205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing TCR gene transfer.
    Heemskerk MH
    Clin Immunol; 2006 May; 119(2):121-2. PubMed ID: 16503199
    [No Abstract]   [Full Text] [Related]  

  • 40. Redirecting T lymphocyte specificity by T cell receptor gene transfer--a new era for immunotherapy.
    Engels B; Uckert W
    Mol Aspects Med; 2007 Feb; 28(1):115-42. PubMed ID: 17307249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.